Leptin/adiponectin ratio in obese women with and without binge eating disorder

Neuroendocrinology Letters

Volumn 31, Issue 3, 2010, Pages 353-358

  Paraguassu Brandao, Paula ^a   Garcia Souza, Erica Patricia ^a   Alves Neves, Fabiana ^a   Dos Santos Pereira, Mario Jose ^a   Sichieri, Rosely ^a   Gaspar De Moura, Egberto ^a   Lisboa Da Silva, Patricia Cristina ^a   Sanchez Moura, Anibal ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adiponectin; Binge eating disorder; Leptin; Leptin adiponectin ratio; Obesity

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; ARTICLE; BINGE EATING DISORDER; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; OBESITY; BLOOD; COMPARATIVE STUDY; COMPLICATION;

ADIPONECTIN; ADULT; BINGE-EATING DISORDER; BODY MASS INDEX; FEMALE; HUMANS; LEPTIN; OBESITY;

EID: 77955453564     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adami G, Campostano A, Cella F, Ferrandes G (2002). Serum leptin level and restrained eating: Study with the eating disorder examination. Physiol Behav. 75: 189-192. (Pubitemid 34226909)
2. American Psychiatry Association (APA) (1994). Diagnostic and statistical; in APA. ed: Manual of Mental Disorders. Washington, DC.
3. Bouloumie A, Drexler HC, Lafontan M, Busse R (1998). Leptin, the product of ob gene+ promotes angiogenesis. Circ Res. 83: 1059-1066.
4. Carnier J, Lofrano MC, Prado WL, Caranti DA, de Piano A, Tock L, do Nascimento CM, Oyama LM, Mello MT, Tufik S, Damaso AR (2008). Hormonal alteration in obese adolescents with eating disorder: Effects of multidisciplinary therapy. Horm Res. 70: 79-84.
5. Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB (2001). Plasma insulin, leptin, and soluble tnf receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis. 157: 495-503.
6. Devlin MJ, Walsh BT, Guss JL, Kissileff HR, Liddle RA, Petkova E (1997). Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr. 65: 114-120.
7. Fusco A, Bianchi A, Mancini A, Milardi D, Giampietro A, Cimino V, Porcelli T, Romualdi D, Guido M, Lanzone A, Pontecorvi A, De Marinis L (2007). Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest. 30: 948-956. (Pubitemid 351350831)
8. Geliebter A, Gluck ME, Hashim SA (2005). Plasma ghrelin concentrations are lower in binge-eating disorder. J Nutr. 135: 1326-1330. (Pubitemid 40638358)
9. Gormally J, Black S, Daston S, Rardin D (1982). The assessment of binge eating severity among obese persons. Addict Behav. 7: 47-55.
10. Guzik TJ, Mangalat D, Korbut R (2006). Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol. 57: 505-528.
11. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 20: 1595-1599.
12. Housova J, Kiziova J, Anderlova K, Papezova H, Haluzik M (2005). [serum concentrations of adiponectin in patients with restrictive and purgative subtype of mental anorexia]. Cas Lek Cesk. 144: 278-281.
13. Hyun YJ, Koh SJ, Chae JS, Kim JY, Kim OY, Lim HH, Jang Y, Park S, Ordovas JM, Lee JH (2008). Atherogenecity of ldl and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity (Silver Spring). 16: 784-789.
14. Jequier E (2002). Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci. 967: 379-388. (Pubitemid 34721923)
15. Kempa A, Krzyzanowska-Swiniarska B, Miazgowski T, Pilarska K (2007). Not insulin but insulin sensitivity, leptin, and cortisol are major factors regulating serum acylated ghrelin level in healthy women. J Endocrinol Invest. 30: 659-665.
16. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G (2003). Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 52: 1779-1785.
17. Kotani K, Sakane N (2006). [leptin-to-adiponectin ratio as a new marker associated with metabolic disease]. Nippon Rinsho. 64 Suppl 9: 540-543.
18. Kozlowska L, Rosolowska-Huszcz D (2004). Leptin, thyrotropin, and thyroid hormones in obese/overweight women before and after two levels of energy deficit. Endocrine. 24: 147-153.
19. Kumagai S, Kishimoto H, Masatakasuwa, Zou B, Harukasasaki (2005). The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metab Syndr Relat Disord. 3: 85-94. (Pubitemid 41269266)
20. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, Bastard JP (2004). Systemic low-grade inflammation is related to both circulating and adipose tissue tnfalpha, leptin and il-6 levels in obese women. Int J Obes Relat Metab Disord. 28: 993-997.
21. Maahs DM, Hamman RF, D'Agostino R Jr., Dolan LM, Imperatore G, Lawrence JM, Marcovina SM, Mayer-Davis EJ, Pihoker C, Dabelea D (2009). The association between adiponectin/leptin ratio and diabetes type: The search for diabetes in youth study. J Pediatr. 155: 133-135, 135 e131.
22. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 89: 1102-1107.
23. Marchesini G, Cuzzolaro M, Mannucci E, Dalle Grave R, Gennaro M, Tomasi F, Barantani EG, Melchionda N (2004). Weight cycling in treatment-seeking obese persons: Data from the quovadis study. Int J Obes Relat Metab Disord. 28: 1456-1462.
24. Markowska A, Malendowicz K, Drews K (2004). The role of leptin in breast cancer. Eur J Gynaecol Oncol. 25: 192-194.
25. Matsubara M, Katayose S, Maruoka S (2003). Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol. 148: 343-350. (Pubitemid 36410720)
26. Matsubara M, Maruoka S, Katayose S (2002). Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 147: 173-180.
27. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 9: 5699-5704.
28. Monteleone P, Di Lieto A, Tortorella A, Longobardi N, Maj M (2000). Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: Relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Res. 94: 121-129.
29. Monteleone P, Fabrazzo M, Martiadis V, Fuschino A, Serritella C, Milici N, Maj M (2003). Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder. J Clin Endocrinol Metab. 88: 5387-5391. (Pubitemid 37452743)
30. Nazal L, Riquelme A, Solis N, Pizarro M, Escalona A, Burotto M, Mendez JI, Saint-Jean C, Concha MJ, Giovanni S, Awruch D, Morales A, Baudrand R, Carrasco G, Dominguez MA, Padilla O, Espinoza M, Miquel JF, Nervi F, Arrese M (2010). Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. Obes Surg. Jan 12. [Epub ahead of print]
31. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M (2008). The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism. 57: 268-273.
32. Sari R, Balci MK, Altunbas H, Karayalcin U (2003). The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol (Oxf ). 59: 258-262.
33. Tagami T, Satoh N, Usui T, Yamada K, Shimatsu A, Kuzuya H (2004). Adiponectin in anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab. 89: 1833-1837.
34. Tessitore L, Vizio B, Jenkins O, De Stefano I, Ritossa C, Argiles JM, Benedetto C, Mussa A (2000). Leptin expression in colorectal and breast cancer patients. Int J Mol Med. 5: 421-426.
35. Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, Liuzzi A, Di Blasio AM (2007). Deep subcutaneous adipose tissue: A distinct abdominal adipose depot. Obesity (Silver Spring). 15: 1933-1943. (Pubitemid 47402225)
36. Weigle DS, Breen PA, Matthys CC, Callahan HS, Meeuws KE, Burden VR, Purnell JQ (2005). A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 82: 41-48.
37. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T (2002). Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the japanese population. Clin Sci (Lond). 103: 137-142.
38. Yamauchi T, Inoue K, Iwasaki S, Muramatsu T, Hayashi T, Kiriike N (2009). Intracerebroventricular administration of leptin increases anxiety-like behavior in female rats after semi-starvation - implications for anxiety in eating disorders. Osaka City Med J. 55: 9-18.
39. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM (2002). Plasma adiponectin levels in overweight and obese asians. Obes Res. 10: 1104-1110. (Pubitemid 135686651)
40. Zeman M, Jirak R, Jachymova M, Vecka M, Tvrzicka E, Zak A (2009). Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinol Lett. 30: 387-395.